Trial Profile
Induction Chemotherapy of Docetaxel, Cisplatin and Xeloda in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Aug 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 16 Jun 2016 New trial record